Collection needs fluctuate—so you need flexibility. The Trima Accel system streamlines the collection of any transfusable component in any combination. It is the only apheresis system on the market today with the versatility blood centers need for full-spectrum component combinations—helping you to meet your collection goals with a single device. This flexibility and agility have helped make the Trima Accel system one of the world’s leading apheresis devices.
Pair the device with powerful software options designed to match component needs and optimize collections, helping you do more with less.
Collects Higher-Quality Blood Components
Keeps Donors Safe
The Trima Accel system collects the targeted component(s) based on two important criteria:
The system includes the Trima Accel device, a variety of tubing sets and system software.
To help you meet your blood center’s collection goals, you can configure desired product volumes, yields and combinations. In addition, you can ensure that final products meet specifications by calibrating the device to your blood center’s cell counter.
1Trochinski JM, et al., “Cost Savings as a Result of Standardizing Apheresis Platforms.” Transfusion 2012; 53 (Suppl.): 240A.
2Tobian A., et al., "Platelet Corrected Count Increments by Apheresis Platform.” Transfusion 2016; doi:10.1111/trf.13788.
3Bravo M., et al., "Detection of Bacterial Contamination in Apheresis Platelets: Is Apheresis Technology a Factor?” Transfusion 2016, 55: 2113–2122. doi:10.1111/trf.13107.
4Bueno, JL, et al., "A Randomized Crossover Trial Comparing Three Plateletpheresis Machines." Transfusion 2005; 45: 1373–1381. (Paired Study).
5Hubbard B and B Fulmer, "Increasing Donor Satisfaction Through the Use of Single-Needle Procedures." Transfusion 2009; 49 (Suppl.): 250A.
Products available in select markets.